Logo image of ALBI.PA

GASCOGNE (ALBI.PA) Stock Fundamental Analysis

EPA:ALBI - Euronext Paris - Matif - FR0000124414 - Common Stock - Currency: EUR

2.36  +0.06 (+2.61%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALBI. ALBI was compared to 14 industry peers in the Containers & Packaging industry. ALBI may be in some trouble as it scores bad on both profitability and health. ALBI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALBI had negative earnings in the past year.
In the past year ALBI had a positive cash flow from operations.
ALBI had positive earnings in 4 of the past 5 years.
Each year in the past 5 years ALBI had a positive operating cash flow.
ALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

ALBI has a Return On Assets of -0.10%. This is in the lower half of the industry: ALBI underperforms 71.43% of its industry peers.
ALBI has a Return On Equity of -0.29%. This is in the lower half of the industry: ALBI underperforms 71.43% of its industry peers.
ALBI's Return On Invested Capital of 0.88% is on the low side compared to the rest of the industry. ALBI is outperformed by 64.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALBI is below the industry average of 6.59%.
Industry RankSector Rank
ROA -0.1%
ROE -0.29%
ROIC 0.88%
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)5.63%
ROE(5y)6.16%
ROIC(3y)4.1%
ROIC(5y)4.24%
ALBI.PA Yearly ROA, ROE, ROICALBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

Looking at the Operating Margin, with a value of 1.55%, ALBI is doing worse than 71.43% of the companies in the same industry.
ALBI's Operating Margin has declined in the last couple of years.
ALBI has a worse Gross Margin (25.55%) than 71.43% of its industry peers.
In the last couple of years the Gross Margin of ALBI has remained more or less at the same level.
Industry RankSector Rank
OM 1.55%
PM (TTM) N/A
GM 25.55%
OM growth 3Y-27.15%
OM growth 5Y-15.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.26%
ALBI.PA Yearly Profit, Operating, Gross MarginsALBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALBI is creating some value.
Compared to 1 year ago, ALBI has more shares outstanding
The number of shares outstanding for ALBI has been increased compared to 5 years ago.
Compared to 1 year ago, ALBI has a worse debt to assets ratio.
ALBI.PA Yearly Shares OutstandingALBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALBI.PA Yearly Total Debt VS Total AssetsALBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALBI has an Altman-Z score of 1.29. This is a bad value and indicates that ALBI is not financially healthy and even has some risk of bankruptcy.
ALBI has a Altman-Z score of 1.29. This is in the lower half of the industry: ALBI underperforms 78.57% of its industry peers.
A Debt/Equity ratio of 1.19 is on the high side and indicates that ALBI has dependencies on debt financing.
ALBI's Debt to Equity ratio of 1.19 is on the low side compared to the rest of the industry. ALBI is outperformed by 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACC0.23
WACC3.79%
ALBI.PA Yearly LT Debt VS Equity VS FCFALBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALBI has a Current Ratio of 1.79. This is a normal value and indicates that ALBI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.79, ALBI is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
ALBI has a Quick Ratio of 1.07. This is a normal value and indicates that ALBI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALBI (1.07) is better than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.07
ALBI.PA Yearly Current Assets VS Current LiabilitesALBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALBI have decreased strongly by -122.74% in the last year.
Looking at the last year, ALBI shows a decrease in Revenue. The Revenue has decreased by -4.87% in the last year.
The Revenue has been growing slightly by 0.07% on average over the past years.
EPS 1Y (TTM)-122.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.98%
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y-0.64%
Revenue growth 5Y0.07%
Sales Q2Q%7.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBI.PA Yearly Revenue VS EstimatesALBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBI.PA Price Earnings VS Forward Price EarningsALBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

71.43% of the companies in the same industry are more expensive than ALBI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.18
ALBI.PA Per share dataALBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GASCOGNE

EPA:ALBI (6/27/2025, 7:00:00 PM)

2.36

+0.06 (+2.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.62%
Ins Owner ChangeN/A
Market Cap88.92M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF 4.06
P/B 0.41
P/tB 0.44
EV/EBITDA 7.18
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.13
FCFYN/A
OCF(TTM)0.58
OCFY24.6%
SpS10.38
BVpS5.69
TBVpS5.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -0.29%
ROCE 1.29%
ROIC 0.88%
ROICexc 1.11%
ROICexgc 1.15%
OM 1.55%
PM (TTM) N/A
GM 25.55%
FCFM N/A
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)5.63%
ROE(5y)6.16%
ROIC(3y)4.1%
ROIC(5y)4.24%
ROICexc(3y)4.63%
ROICexc(5y)4.82%
ROICexgc(3y)4.81%
ROICexgc(5y)5.01%
ROCE(3y)6.32%
ROCE(5y)6.56%
ROICexcg growth 3Y-40.81%
ROICexcg growth 5Y-24.33%
ROICexc growth 3Y-40.44%
ROICexc growth 5Y-24.35%
OM growth 3Y-27.15%
OM growth 5Y-15.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.26%
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Debt/EBITDA 8.29
Cap/Depr 260.52%
Cap/Sales 16.52%
Interest Coverage 1.29
Cash Conversion 70.88%
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.07
Altman-Z 1.29
F-Score3
WACC3.79%
ROIC/WACC0.23
Cap/Depr(3y)285.57%
Cap/Depr(5y)222.94%
Cap/Sales(3y)15.49%
Cap/Sales(5y)11.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y-0.64%
Revenue growth 5Y0.07%
Sales Q2Q%7.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.43%
EBIT growth 3Y-27.62%
EBIT growth 5Y-15.79%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.07%
OCF growth 3Y-14.16%
OCF growth 5Y0.18%